Headlines

Less Than Two Hours Before The Market Open, LendingTree Is Down By 4%

(VIANEWS) – The NASDAQ opens in less than two hours and LendingTree‘s pre-market value is already 4.32% down. LendingTree’s last close was $36.11, 12.5% under its 52-week high of $41.27. The last session, NASDAQ ended with LendingTree (TREE) sliding 1.23% to $36.11. NASDAQ dropped 0.82% to $15,775.65, following the last session’s downward trend on what…

Read More

Viking Therapeutics Stock Was 13.66% Up On Monday

(VIANEWS) – The NASDAQ ended the session with Viking Therapeutics (VKTX) rising 13.66% to $36.20 on Monday while NASDAQ dropped 0.82% to $15,775.65. Viking Therapeutics’s last close was $36.20, 2.74% below its 52-week high of $37.22. About Viking Therapeutics Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic…

Read More

Viking Therapeutics Stock Was 15.16% Up Before The Weekend

(VIANEWS) – The NASDAQ ended the session with Viking Therapeutics (VKTX) rising 15.16% to $36.68 on Friday while NASDAQ slid 0.82% to $15,775.65. Viking Therapeutics’s last close was $31.85, 23.83% above its 52-week high of $25.72. About Viking Therapeutics Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic…

Read More

Less Than Two Hours Before The Market Open, Xenetic Biosciences Is Up By 10%

(VIANEWS) – The NASDAQ opens in less than two hours and Xenetic Biosciences‘s pre-market value is already 10.11% up. Xenetic Biosciences’s last close was $3.56, 52.53% below its 52-week high of $7.50. The last session, NASDAQ finished with Xenetic Biosciences (XBIO) sliding 8.72% to $3.56. NASDAQ rose 0.3% to $15,906.17, after two consecutive sessions in…

Read More

NeuroMetrix Stock Rise On Thursday, Outperforms Market

(VIANEWS) – The NASDAQ ended the session with NeuroMetrix (NURO) jumping 9.9% to $3.33 on Thursday while NASDAQ jumped 0.3% to $15,906.17. NeuroMetrix’s last close was $3.03, 79.85% below its 52-week high of $15.04. About NeuroMetrix NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze…

Read More